Literature DB >> 19694827

Chromosomal abnormalities determined by comparative genomic hybridization are helpful in the diagnosis of atypical hepatocellular neoplasms.

Sanjay Kakar1, Xin Chen, Coral Ho, Lawrence J Burgart, Oyedele Adeyi, Dhanpat Jain, Viabhav Sahai, Linda D Ferrell.   

Abstract

AIMS: To explore the utility of cytogenetic abnormalities in the distinction of hepatic adenoma (HA) and well-differentiated hepatocellular carcinoma (HCC). METHODS AND
RESULTS: Array-based comparative genomic hybridization (CGH) was used to determine chromosomal abnormalities in 39 hepatocellular neoplasms: 12 HA, 15 atypical hepatocellular neoplasms (AHN) and 12 well-differentiated HCC. The designation of AHN was used in two situations: (i) adenoma-like neoplasms (n = 8) in male patients (any age) and women >50 years and <15 years old; (ii) adenoma-like neoplasms with focal atypical features (n = 7). CGH abnormalities were seen in none of the HAs (0/12), eight (53%) AHNs and 11 (92%) HCCs. The number and nature of abnormalities in AHN was similar to HCC with gains in 1q, 8q and 7q being the most common. Although follow-up information was limited, recurrence and/or metastasis were observed in three AHNs (two with abnormal, one with normal CGH).
CONCLUSIONS: Adenoma-like neoplasms with focal atypical morphological features or unusual clinical settings such as male gender or women outside the 15-50 year age group can show chromosomal abnormalities similar to well-differentiated HCC. Even though these tumours morphologically mimic adenoma, they can recur and metastasize. Determination of chromosomal abnormalities can be useful in the diagnosis of AHN.

Entities:  

Mesh:

Year:  2009        PMID: 19694827      PMCID: PMC3727398          DOI: 10.1111/j.1365-2559.2009.03343.x

Source DB:  PubMed          Journal:  Histopathology        ISSN: 0309-0167            Impact factor:   5.087


  44 in total

1.  Fully automatic quantification of microarray image data.

Authors:  Ajay N Jain; Taku A Tokuyasu; Antoine M Snijders; Richard Segraves; Donna G Albertson; Daniel Pinkel
Journal:  Genome Res       Date:  2002-02       Impact factor: 9.043

2.  Glypican-3 expression in hepatocellular tumors: diagnostic value for preneoplastic lesions and hepatocellular carcinomas.

Authors:  Xiao Ying Wang; Françoise Degos; Sylvie Dubois; Sandrine Tessiore; Mark Allegretta; Ronald D Guttmann; Serge Jothy; Jacques Belghiti; Pierre Bedossa; Valérie Paradis
Journal:  Hum Pathol       Date:  2006-08-10       Impact factor: 3.466

3.  Hepatocellular adenoma. Its transformation to carcinoma in a user of oral contraceptives.

Authors:  H Tesluk; J Lawrie
Journal:  Arch Pathol Lab Med       Date:  1981-06       Impact factor: 5.534

4.  Value of glypican 3 immunostaining in the diagnosis of hepatocellular carcinoma on needle biopsy.

Authors:  Florencia Anatelli; Shang-Tian Chuang; Ximing J Yang; Hanlin L Wang
Journal:  Am J Clin Pathol       Date:  2008-08       Impact factor: 2.493

5.  Utility and limitations of glypican-3 expression for the diagnosis of hepatocellular carcinoma at both ends of the differentiation spectrum.

Authors:  Nafis Shafizadeh; Linda D Ferrell; Sanjay Kakar
Journal:  Mod Pathol       Date:  2008-06-06       Impact factor: 7.842

6.  Trisomy 1 and 8 occur frequently in hepatocellular carcinoma but not in liver cell adenoma and focal nodular hyperplasia. A fluorescence in situ hybridization study.

Authors:  A Nasarek; M Werner; M Nolte; J Klempnauer; A Georgii
Journal:  Virchows Arch       Date:  1995       Impact factor: 4.064

7.  Distinct pathways of genomic progression to benign and malignant tumors of the liver.

Authors:  Aaron D Tward; Kirk D Jones; Stephen Yant; Siu Tim Cheung; Sheung Tat Fan; Xin Chen; Mark A Kay; Rong Wang; J Michael Bishop
Journal:  Proc Natl Acad Sci U S A       Date:  2007-09-04       Impact factor: 11.205

8.  Liver cell adenoma with concomitant hepatocellular carcinoma: report of two cases.

Authors:  Wen-Yu Chuang; Tse-Ching Chen; Hui-Ling Hsu; Wei-Chen Lee; Long-Bin Jeng; Shiu-Feng Huang
Journal:  J Formos Med Assoc       Date:  2002-11       Impact factor: 3.282

Review 9.  Multiple hepatic adenomas after long-term therapy with testosterone enanthate. Review of the literature.

Authors:  D Carrasco; M Prieto; L Pallardó; J L Moll; J M Cruz; C Muñoz; J Berenguer
Journal:  J Hepatol       Date:  1985       Impact factor: 25.083

10.  Hepatocellular carcinoma and the penetrance of HFE C282Y mutations: a cross sectional study.

Authors:  Gavin Willis; Vicky Bardsley; Ian W Fellows; Ray Lonsdale; Jennie Z Wimperis; Barbara A Jennings
Journal:  BMC Gastroenterol       Date:  2005-06-01       Impact factor: 3.067

View more
  13 in total

Review 1.  Malignant transformation of hepatocellular adenoma.

Authors:  Christine Sempoux; Charles Balabaud; Paulette Bioulac-Sage
Journal:  Hepat Oncol       Date:  2014-12-11

2.  Genomic losses at 5q13.2 and 8p23.1 in dysplastic hepatocytes are common events in hepatitis B virus-related hepatocellular carcinoma.

Authors:  Zhang Zhao; Guang-Yong Chen; Jiang Long; Hai Li; Jian Huang
Journal:  Oncol Lett       Date:  2015-04-23       Impact factor: 2.967

3.  Hepatocellular carcinoma arising in adenoma: similar immunohistochemical and cytogenetic features in adenoma and hepatocellular carcinoma portions of the tumor.

Authors:  Sanjay Kakar; James P Grenert; Valerie Paradis; Nicolas Pote; Shriram Jakate; Linda D Ferrell
Journal:  Mod Pathol       Date:  2014-04-18       Impact factor: 7.842

4.  Combined use of heat-shock protein 70 and glutamine synthetase is useful in the distinction of typical hepatocellular adenoma from atypical hepatocellular neoplasms and well-differentiated hepatocellular carcinoma.

Authors:  Thuy B Nguyen; Massimo Roncalli; Luca Di Tommaso; Sanjay Kakar
Journal:  Mod Pathol       Date:  2016-01-15       Impact factor: 7.842

5.  Atypical hepatocellular adenoma-like neoplasms with β-catenin activation show cytogenetic alterations similar to well-differentiated hepatocellular carcinomas.

Authors:  Kimberley J Evason; James P Grenert; Linda D Ferrell; Sanjay Kakar
Journal:  Hum Pathol       Date:  2012-10-16       Impact factor: 3.466

6.  A meta-analysis of array-CGH studies implicates antiviral immunity pathways in the development of hepatocellular carcinoma.

Authors:  Xu Guo; Xi Ma; Jiaze An; Yukui Shang; Qichao Huang; Hushan Yang; Zhinan Chen; Jinliang Xing
Journal:  PLoS One       Date:  2011-12-12       Impact factor: 3.240

Review 7.  Identification of drivers from cancer genome diversity in hepatocellular carcinoma.

Authors:  Atsushi Takai; Hien T Dang; Xin W Wang
Journal:  Int J Mol Sci       Date:  2014-06-20       Impact factor: 5.923

8.  Morphologic and Molecular Findings in Myxoid Hepatic Adenomas.

Authors:  Daniel J Rowan; Saba Yasir; Zongming E Chen; Taofic Mounajjed; Sibel Erdogan Damgard; Lisa Cummins; Lizhi Zhang; Emma Whitcomb; Vince Falck; Sanford M Simon; Aatur D Singhi; Michael S Torbenson
Journal:  Am J Surg Pathol       Date:  2021-08-01       Impact factor: 6.298

Review 9.  Molecular alterations in hepatocellular carcinoma associated with hepatitis B and hepatitis C infections.

Authors:  Maria Lina Tornesello; Luigi Buonaguro; Francesco Izzo; Franco M Buonaguro
Journal:  Oncotarget       Date:  2016-05-03

10.  Atypical Hepatocellular Neoplasm With Peliosis in Cirrhotic Liver Versus Hepatocellular Carcinoma: A Diagnostic Trap.

Authors:  Simona Gurzu; Ioan Jung; Anca Otilia Contac; Mihai Turcu; Adrian Tudor
Journal:  Medicine (Baltimore)       Date:  2015-07       Impact factor: 1.817

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.